As best practices, investors should check what assets the business owns and what unique selling point it can show. GERMANY IS AT a turning point — the government’s approval of the Cannabis Act (CanG), a bill to legalize adult-use cannabis within the country, is expected to be in practice in early 2024. Despite this good news, many currently licensed medical cannabis companies were hoping for the legalization of the entire value chain as outlined in…